Target intelligence / Profile preview

Ocular surface mucin layer and tear film

Molecular classification
Glycoprotein, Lipid, Other
01

Overview

The ocular surface mucin layer and tear film constitute a complex, multi-layered fluid system essential for maintaining the health and optical clarity of the eye (Craig et al., 2017). This system is traditionally described as having three components: an outer lipid layer that prevents evaporation, a middle aqueous layer containing nutrients and antimicrobial proteins, and an inner mucin layer (glycocalyx) that anchors the tear film to the hydrophobic corneal epithelium (Gipson, 2004). Mucins, such as MUC1, MUC4, MUC16, and the secreted MUC5AC, play a pivotal role in lubrication, hydration, and providing a barrier against pathogens and environmental debris (Mantelli & Argüeso, 2008). Dysfunction or deficiency in any of these components leads to dry eye disease (DED), characterized by tear film instability, hyperosmolarity, and ocular surface inflammation (TFOS DEWS II, 2017). Therapeutic strategies targeting this system include the use of mucin secretagogues like rebamipide and diquafosol, which enhance the production of protective glycoproteins (Lau et al., 2014). Additionally, anti-inflammatory agents like cyclosporine and lifitegrast are employed to stabilize the tear film and restore the homeostatic environment of the ocular surface by preventing goblet cell loss (Pflugfelder & Stern, 2020).

Other names
Pre-corneal tear filmOcular surface glycocalyxTear film mucin layerTear film
02

Mechanism of action

Stimulation of mucin secretion from goblet cells and corneal/conjunctival epithelia; stabilization of the tear film lipid layer; reduction of surface tension; anti-inflammatory modulation to prevent goblet cell loss (Lau et al., 2014; Pflugfelder & Stern, 2020).

03

Biological functions

LubricationHydrationImmune responseRefractionCell signalingOcular surface protection
04

Disease associations

Dry eye diseaseInflammationInfectionSjögren's syndromeMeibomian gland dysfunctionVitamin A deficiency
05

Safety considerations

Transient blurred visionOcular irritationBurning sensationForeign body sensationHypersensitivity reactions
06

Interacting drugs

Rebamipide

5 more in the full profile.

07

Biomarkers

Tear break-up time (TBUT)Schirmer test scoreTear film osmolarityMUC5AC concentration in tearsRose Bengal stainingLissamine Green staining

Beyond the preview

Go deeper on Ocular surface mucin layer and tear film.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ocular surface mucin layer and tear film.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call